NCT02872870

Brief Summary

This study will help to better characterize oral and written language disorders and determine if these disorders are continuous or not. The participants ( dyslexic and dysphasic patients and control adults) will carry out an auditory lexical decision task during which an electroencephalogram (EEG) will be recorded.

Trial Health

90
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
196

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Mar 2012

Longer than P75 for all trials

Geographic Reach
2 countries

3 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2012

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2015

Completed
1.3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2016

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

August 16, 2016

Completed
3 days until next milestone

First Posted

Study publicly available on registry

August 19, 2016

Completed
Last Updated

August 19, 2016

Status Verified

August 1, 2016

Enrollment Period

3 years

First QC Date

August 16, 2016

Last Update Submit

August 16, 2016

Conditions

Keywords

language disordersdevelopmental disorders of oral and written language

Outcome Measures

Primary Outcomes (5)

  • Score Alouette reading test

    In this test, the participant has to read in a loud voice a text, during three minutes. The final score takes into account the speed and the number of errors. For test performance, clinical groups will be compared with its controls.

    at inclusion

  • Score EVALEC reading test

    For test performance, clinical groups will be compared with its controls.

    at inclusion

  • Score silence reading test

    A group of letters will be presented and the participant has to say if this letters compose a known word. For test performance, clinical groups will be compared with its controls.

    at inclusion

  • Score of reading comprehension test

    For test performance, clinical groups will be compared with its controls.

    at inclusion

  • Score of Khomsi

    The objective of this group of different tests is to evaluate comprehension and production of oral language. For test performance, clinical groups will be compared with its controls.

    at inclusion

Secondary Outcomes (2)

  • Measure of the electroencephalography power spectra

    at inclusion

  • Correlation between electroencephalography power spectra and clinical outcome

    at inclusion

Study Arms (3)

Control adults

lexical tests and electroencephalogram (EEG).

Behavioral: auditory lexical decision taskDevice: electroencephalogram

Dyslexic patients

lexical tests

Behavioral: auditory lexical decision taskDevice: electroencephalogram

Dysphasic patients

lexical tests

Behavioral: auditory lexical decision taskDevice: electroencephalogram

Interventions

Control adultsDyslexic patientsDysphasic patients
Control adultsDyslexic patientsDysphasic patients

Eligibility Criteria

Age8 Years+
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The study population consists of 3 groups. A group of volunteers (controls), a group of patients with oral language disorders, a group of patients with written language disorders.

You may qualify if:

  • Non-verbal intelligence quotient (IQ) less than 85 according to the Wechsler Intelligence Scale for Children (WISC) perceptual index
  • Specific oral language disorders diagnosed by the multidisciplinary team (neurologist, psychologist, speech therapist): understanding language deficit, estimated by the test SCOTLAND (Lecocq, 1996) and / or vocabulary test (Dunn Thiébaud).
  • Specific written language disorders (dyslexia) diagnosed by a multidisciplinary team according to a test that can objectify the late reading (Alouette) and locate deficits (EVALEC)
  • Be affiliated to a social security regimen
  • Have signed an informed consent or signed by the parents if the patient is minor
  • Aged at least 8 years old
  • Non-deficit (\>85) non-verbal Wechsler Scale (codes and matrices)
  • No specific oral language disorders
  • No specific written language disorders (dyslexia)
  • Be affiliated to a social security regimen
  • Have signed an informed consent or signed by the parents if the patient is minor
  • Aged at least 8 years old

You may not qualify if:

  • Mother tongue other than French
  • Non-verbal reasoning abilities below 85 measured by the WISC 4 (for patients only) and Non-verbal capacities of reasoning lower than the normal measured by the non-verbal scale of Wechsler (for controls only)
  • Presence of pervasive developmental disorders
  • No affiliation to a social security regimen
  • Absence of signature of the informed consent
  • Subject of less than 8 years

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Université catholique de Louvain (IPSY)

Louvain-la-Neuve, 1348, Belgium

Location

Hôpital Saint Vincent de Paul (GHICL)

Lille, 59000, France

Location

Université de Lille 3 Charles de Gaulle (URECA)

Villeneuve-d'Ascq, 59653, France

Location

MeSH Terms

Conditions

DyslexiaAphasiaLanguage Disorders

Interventions

Electroencephalography

Condition Hierarchy (Ancestors)

Communication DisordersNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSpecific Learning DisorderLearning DisabilitiesSigns and SymptomsPathological Conditions, Signs and SymptomsNeurodevelopmental DisordersMental DisordersSpeech Disorders

Intervention Hierarchy (Ancestors)

Diagnostic Techniques, NeurologicalDiagnostic Techniques and ProceduresDiagnosisElectrodiagnosis

Study Officials

  • Séverine Casalis

    Université de Lille 3

    STUDY DIRECTOR
  • Françoise Boidein, MD

    Groupement des Hôpitaux de l'Institut Catholique de Lille (GHICL)

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 16, 2016

First Posted

August 19, 2016

Study Start

March 1, 2012

Primary Completion

March 1, 2015

Study Completion

June 1, 2016

Last Updated

August 19, 2016

Record last verified: 2016-08

Data Sharing

IPD Sharing
Will not share

Locations